Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP Acute Pancreatitis (Study P02580)(TERMINATED)

NCT00040131 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Bile Duct Diseases
Biliary Tract Diseases
Gallbladder Diseases
Pancreatitis
Pancreatic Diseases

Interventions

DRUG: IL-10

Sponsor

Merck Sharp & Dohme LLC